Top 10 Big Pharma Advertisers vs Top 10 Big Pharma DOJ Fines
May 18, 2015
The Sociopathic Business Model™ maintains that companies that encourage, replicate and reward unethical and or illegal behavior will only change through forced accountability either through government intervention and or if their negative truth is exposed damaging the company image and in turn profits.
Big Pharma and Medical Device pay billion dollar fines without shame, remorse, or guilt and without accountability all at the expense of patients, consumers, employees and taxpayers alike. This site has maintained that many in the industry would rather build billion dollar fines into annual budgets while again encouraging, replicating and rewarding employees who engage in unethical and or illegal activity on behalf of the company rather than actually fixing the problems within the organization. Corruption & fraud are entrenched in the industry business model.
Johnson & Johnson’s constant rebranding or companies spending billions on direct to consumer advertising (DTC) campaigns are often ways for unethical companies, whose exposure of the negative truth they’d rather remain hidden caused damage to image and or profits, can try and mitigate the damages while still avoiding accountability and possibly distance from crimes by only focusing on company image. As consumers this is something we should start (if we haven’t already) paying attention to and not rewarding companies that pathologically without accountability keep committing the same offenses at our expense.
Six of the top ten big pharma DTC advertisers are also the the DOJ’s list of highest paid pharma fines. It’s certainly inconsistent & contradictory language to action for Johnson & Johnson to spend $2.2 Billion in advertising in 2013 and of that $805 million in television dropped to $257.8 million for DTC television advertising in 2014.
Television is by far the most popular medium for DTC prescription drug advertising. It accounted for more than 70% of total spending from the top 10 pharma company dollars spent on advertising, or about $2.44 billion out of $3.4 billion, according to data supplied by Nielsen. Spending by all pharma companies was on an upswing in 2014, topping $4.5 billion, according to Nielsen data, which was an increase of 18% over the $3.8 billion spent in 2013.
Perhaps because Johnson & Johnson through forced accountability has had to pay billions in fines and many victims are still working through the court system it also forced them to cut their advertising spending dramatically from one year to the next.
J&J Is Now Top-Fined Company in the Pharma/Med Device Criminal & Civil Settlement Planetary System: A Blot on Gorsky’s Leadership